3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
42
Lymphoma, Large B-Cell, Diffuse
34
Burkitt Lymphoma
32
Lymphoma
25
Lymphoma, Follicular
17
Rhabdomyosarcoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, B-Cell
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
10
Leukemia
10
Sarcoma, Ewing
9
Medulloblastoma
9
Leukemia, Biphenotypic, Acute
9
Recurrence
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Hodgkin Disease
7
Wilms Tumor
5
Sarcoma
5
Retinoblastoma
5
Osteosarcoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Ganglioneuroblastoma
4
Down Syndrome
4
Interventions
Injections
6
pembrolizumab
5
toripalimab
3
tislelizumab
3
senaparib
3
Bevacizumab
3
sintilimab
2
Technetium
2
Specimen Handling
2
Nivolumab
2
Ipilimumab
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Blood Specimen Collection
2
zimberelimab
1
tumor-cells apoptosis factor, human
1
tazemetostat
1
spartalizumab
1
sacituzumab govitecan
1
rucaparib
1
osimertinib
1
olaparib
1
etoposide phosphate
1
enzalutamide
1
envafolimab
1
cemiplimab
1
cedazuridine
1
atezolizumab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
Vincristine
×
1 year
×
Clear all
No trials found.